Cryolipolysis On Cardiovascular Risk Factors In Obese Hypertensive Post Menopausal Wome

Phase 3

Recruiting

• Conditions: Circulatory System; Musculoskeletal Diseases; Nutritional, Metabolic, Endocrine; post menopause

• Registration Number: PACTR202305888250839
• Lead Sponsor: faculty of physical therapy cairo university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-21
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

The women will be selected according to the following criteria:
•The age will range from 50 to 60 years.
•They will experience menopause at least 3 years.
•The women in the study will be diagnosed as having hypertension.
•Their blood pressure must be range from 140/90 to 180/110 mmHg.
•They must receive antihypertensive drug (Concor 5 mg).
•Body mass index (BMI) will range from 30 to 34.9 kg/m2.
•All women will have abdominal obesity; their abdominal circumference will be >90cm.
•Waist hip ratio will be >0.85.

Exclusion Criteria

Patients will be excluding from this study for any of the following cases:
•Smokers, athletic women.
•Anemia, diabetes, any cardiorespiratory diseases, malignancy.
•Eczema or dermatitis, skin disease, scar, hernia in the treatment area.
•Suspicious cutaneous lesions, history of keloids or hypertrophic scarring, infection, pain or abscess in the treatment area, presence of tattoos or body piercing in the treatment area, autoimmune disorders.
•Presence of pacemaker or metallic implants in the treatment area.
•Receiving anti-depressant, any hormonal replacement therapy, or any medication to reduce their body weight.
•Previous operation in the abdominal region.

Study & Design

• Study Type: Interventional
• Study Design: Not specified